| Term 
 
        | Acetylcholine Pathway, metabolism, receptor
 |  | Definition 
 
        | Pathway: Nucleus basalis of meynert and septum to cerebral cortex and hippocampus, this degenerates in (alzheimers); balance DA in corpus striatum (parkinsons) Metabolism: AcCoA is broght in through nerve, choline is taken up by CHT, inside the nerve terminal ChAT combines the two to make AcH, which is taken up by VAT into vessicles and will later be released; AcH will be taken up again via AcH autoreceptor Receptors: Muscarinic receptors or nicotinic; M1 - widespread, increase IP3 and DAG; M2 - hippocampus and cortex, decrease cAMP, increase K+ so are inhibit neurons; M4 - may help in scizophrenia |  | 
        |  | 
        
        | Term 
 
        | Norepinephrine Pathway, Metabolism, Receptor
 |  | Definition 
 
        | Pathway: locus coeruleus and reticular formation, project throughout the brain Metabolism: Synthesized from Dopamine, which is synthesized from Tyrosine hydroxylase action on tyrosine; stored in vessicles via VMAT; taken up via NET Receptor: A1, A2, B1, B2 A1 - activate PLC, increases IP3 and DAG A2 - decreases Ca influx (presynaptic); increases K conductance to decrease cAMP (postsynaptic) B1 - Wide distribution, increase cAMP, decrease K conductance B2 - Cerebellum, increases cAMP Amphetamines cause NE release, cocaine and some antidepressants inhibit the NE transporter (NET) |  | 
        |  | 
        
        | Term 
 
        | Dopamine Pathway, Metabolism, Receptors
 |  | Definition 
 
        | Pathway: Mesolimbic system; Nigro striatal pathway, degenerates in parkinson's disease causing movment disorders; ventral tegmental area to nucleus accumbens and prefrontal cortex involved in addiction Metabolism: tyrosine is converted to l-dopa via tyrosine hydroxylase, l-dopa is then converted to dopamine Receptors: D and D subtypes D1 - increases cAMP D2 - presynaptic D2r decreases Ca influx; postsynaptic D2r decreases cAMP and increase K conductance via Gi Amphetamine and cocaine inhibit reuptake |  | 
        |  | 
        
        | Term 
 
        | Serotonin Pathway, Metabolism, Receptor
 |  | Definition 
 
        | Pathway: Raphe nucleus to the limbic system and cerebral cortex Metabolism: Tryptophan-> tryptophan hydroxylase -> 5-hydroxytryptophan -> aromatic L amino acid decarboxylase -> serotonin Receptors: 5-HT and subtypes 5-HT1A = increases K conductance and causes hyperopolarization, like GABA 5-HT2A = Increase IP3 and DAG, decrease K conductance, important in schizophrenia 5-HT3 = ligand gated ion channel, increase cation conductance, involved in nausea   |  | 
        |  | 
        
        | Term 
 
        | GABA Pathway, metabolism, receptors
 |  | Definition 
 
        | Main inhibitory NT in brain Receptors:  GABA-A = ionotropic, increased Cl- conductance, neuronal inhibition GABA-B = GPCRs, decrease Ca conductance or increase K conductance |  | 
        |  | 
        
        | Term 
 
        | Glutamate Pathway, Metabolism, Receptors
 |  | Definition 
 
        | Major excitatory AA NT; important in memory and learning and LTP Metabolism: NMDAr is permeable to Ca, Na and K, requires binding of glycine to a modulatory site in order to function Receptors: NMDAr - in all neurons; increases Na and Ca influx AMPA - in almost all neurons; involved in seizures Kainic (kainate) acid receptor- in hippocampus, cerebellum and spinal cord; involved in seizures |  | 
        |  |